Anti-PADI4 monoclonal antibody

Pre-made anti-PADI4 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PADI4/PADI4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T50429-Ab-1/ GM-Tg-hg-T50429-Ab-2Anti-Human PADI4 monoclonal antibodyHuman
GM-Tg-rg-T50429-Ab-1/ GM-Tg-rg-T50429-Ab-2Anti-Rat PADI4 monoclonal antibodyRat
GM-Tg-mg-T50429-Ab-1/ GM-Tg-mg-T50429-Ab-2Anti-Mouse PADI4 monoclonal antibodyMouse
GM-Tg-cynog-T50429-Ab-1/ GM-Tg-cynog-T50429-Ab-2Anti-Cynomolgus/ Rhesus macaque PADI4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T50429-Ab-1/ GM-Tg-felg-T50429-Ab-2Anti-Feline PADI4 monoclonal antibodyFeline
GM-Tg-cang-T50429-Ab-1/ GM-Tg-cang-T50429-Ab-2Anti-Canine PADI4 monoclonal antibodyCanine
GM-Tg-bovg-T50429-Ab-1/ GM-Tg-bovg-T50429-Ab-2Anti-Bovine PADI4 monoclonal antibodyBovine
GM-Tg-equg-T50429-Ab-1/ GM-Tg-equg-T50429-Ab-2Anti-Equine PADI4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T50429-Ab-1/ GM-Tg-hg-T50429-Ab-2; GM-Tg-rg-T50429-Ab-1/ GM-Tg-rg-T50429-Ab-2;
GM-Tg-mg-T50429-Ab-1/ GM-Tg-mg-T50429-Ab-2; GM-Tg-cynog-T50429-Ab-1/ GM-Tg-cynog-T50429-Ab-2;
GM-Tg-felg-T50429-Ab-1/ GM-Tg-felg-T50429-Ab-2; GM-Tg-cang-T50429-Ab-1/ GM-Tg-cang-T50429-Ab-2;
GM-Tg-bovg-T50429-Ab-1/ GM-Tg-bovg-T50429-Ab-2; GM-Tg-equg-T50429-Ab-1/ GM-Tg-equg-T50429-Ab-2
Products NameAnti-PADI4 monoclonal antibody
Formatmab
Target NamePADI4
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PADI4 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T50429-Ag-1Recombinant multi-species PADI4/ PAD/ PAD4 protein
    ORF Viral VectorvGMLV000132human PADI4 Lentivirus particle
    ORF Viral VectorpGMLV000132human PADI4 Lentivirus plasmid
    ORF Viral VectorpGMLPm004459mouse Padi4 Lentivirus plasmid
    ORF Viral VectorvGMLPm004459mouse Padi4 Lentivirus particle


    Target information

    Target IDGM-T50429
    Target NamePADI4
    Gene ID23569,18602,29512,700806,606921,101086072,508161,100049826
    Gene Symbol and SynonymsPAD,PAD4,PADI4,PADI5,PDI4,PDI5
    Uniprot AccessionQ9UM07,O88807
    Uniprot Entry NamePADI4_HUMAN,PADI4_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000159339
    Target ClassificationN/A

    The target: PADI4, gene name: PADI4, also named as PAD, PAD4, PADI5, PDI4, PDI5. This gene is a member of a gene family which encodes enzymes responsible for the conversion of arginine residues to citrulline residues. This gene may play a role in granulocyte and macrophage development leading to inflammation and immune response. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.